Coeptis Therapeutics (ZSQR) Institutional Ownership $8.98 +0.82 (+10.05%) As of 05/22/2026 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Coeptis Therapeutics (NASDAQ:ZSQR)CurrentInstitutional OwnershipPercentage13.88%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$601.02KNumber ofInstitutional Sellers(last 12 months)0 Get ZSQR Insider Trade Alerts Want to know when executives and insiders are buying or selling Coeptis Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ZSQR Institutional Buying and Selling by Quarter Coeptis Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2026 Marshall Wace LLP18,192$259K0.0%N/A0.341% 2/13/2026 State Street Corp26,830$382K0.0%+35.0%0.502% 2/12/2026 Steward Partners Investment Advisory LLC5,000$71K0.0%+100.0%0.094% 2/9/2026 Geode Capital Management LLC42,097$600K0.0%+12.6%0.788% 11/18/2025 Yorkville Advisors Global LP8,000$140K0.0%N/A0.166% 2/13/2024Armistice Capital LLC3,520,000$2.76M0.0%+59.1%10.320% 11/15/2023Armistice Capital LLC2,212,000$2.57M0.0%-5.1%8.799% 8/15/2023Ionic Capital Management LLC45,000$70K0.0%N/A0.209% 7/21/2023Creative Planning645,103$1M0.0%N/A2.995% 5/12/2023Antara Capital LP45,000$64K0.0%N/A0.220% 2/14/2023Susquehanna International Group LLP16,341$25K0.0%N/A0.319% 2/10/2023Creative Planning645,103$988K0.0%N/A12.600% 2/10/2023HRT Financial LP172,635$267K0.0%N/A3.372% 2/8/2023Cambridge Investment Research Advisors Inc.31,670$48K0.0%N/A0.619% 2/6/2023West Chester Capital Advisors Inc.2,863,382$4.39M8.7%N/A55.925% ZSQR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZSQR shares? During the previous two years, the following institutional investors and hedge funds held shares of Coeptis Therapeutics shares: Geode Capital Management LLC ($600K), State Street Corp ($382K), Marshall Wace LLP ($259K), and Yorkville Advisors Global LP ($140K), Steward Partners Investment Advisory LLC ($71K).Learn more on Coeptis Therapeutics' institutional investors. What percentage of Coeptis Therapeutics' stock is owned by institutional investors? 13.88% of Coeptis Therapeutics' stock is owned by institutional investors. Learn more on ZSQR's institutional investor holdings. Which institutional investors have been buying Coeptis Therapeutics' stock? The following institutional investors have purchased Coeptis Therapeutics' stock in the last 24 months: Marshall Wace LLP ($18.19K), Yorkville Advisors Global LP ($8K), State Street Corp ($6.96K), Geode Capital Management LLC ($4.72K), and Steward Partners Investment Advisory LLC ($2.50K). How much institutional buying is happening at Coeptis Therapeutics? Institutional investors have bought a total of 40,375 shares in the last 24 months. This purchase volume represents approximately $601.02K in transactions. Related Companies Fate Therapeutics Major Shareholders Voyager Therapeutics Major Shareholders Whitehawk Therapeutics Major Shareholders Unicycive Therapeutics Major Shareholders Innate Pharma Major Shareholders Tenax Therapeutics Major Shareholders Black Diamond Therapeutics Major Shareholders Aurora Cannabis Major Shareholders Context Therapeutics Major Shareholders Tiziana Life Sciences Major Shareholders This page (NASDAQ:ZSQR) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
